Results 171 to 180 of about 1,766,409 (315)

Primary analysis of malignant neoplasm trends and demographics in hospitalized patients in Kashi prefecture from 2016 to 2023. [PDF]

BMC Cancer
Kade N, Yakufu W, Zhang C, Wang L, Qian Q, Liu X, Jia L, Wu C, Chen W, Chen T.   +9 more
europepmc   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source

Intrathoracic Neoplasm.—Post-Mortem Report on Case Previously Shown.—Specimen (Lymphosarcoma) [PDF]

, 1929
F. J. Poynton
openalex   +1 more source

Burden of digestive system neoplasms in middle-aged and elderly adults: Temporal trends and geographic disparities (1990-2021). [PDF]

PLoS One
Chai Y, Xu T, Chen B, Wu Y, He Y, Qiu S.
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

On the Use of Radon in the Treatment of Neoplasms of the Skin [PDF]

, 1930
R. T. Brain
openalex   +1 more source

Luvometinib in patients with Langerhans cell histiocytosis, Erdheim-Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study. [PDF]

EClinicalMedicine
Cao XX, Zhu Q, Cai Z, Ma J, Zhou H, Chang L, Zhong LP, Wu ZL, Wang X, Han P, Lin HM, Wei Z, Guo JY, Zheng Y, Li J.   +14 more
europepmc   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

Molecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo   +15 more
wiley   +1 more source

Advanced Osteo-Arthropathy in a Case of Pulmonary Neoplasm [PDF]

, 1930
Harold Avery
openalex   +1 more source

End-to-end deep learning model for the diagnosis and segmentation of primary retroperitoneal neoplasm: a multicenter cohort study. [PDF]

EClinicalMedicine
Feng X, Zhang Q, Yang Y, He H, Yang L, Zhao T, Li Q, Yang L, Gu Y, Chen Q, Deng L, Song Z, Kang F, Liang B, Feng C, Yang Q, Xu B, Zhuang A, Zhang Y, Wang X, Cui J, Li S, Yang P, Hao Q, Zhang Z, Gao J, Wang B, Meng T, Shao C, Chen R.   +29 more
europepmc   +1 more source